FIELD: medicine, ophthalmology. SUBSTANCE: a cornea is kept in a solution which includes hyaluronic acid at 50000-15000 Da molecular weight and its pharmaceutically acceptable salt at 1-20 mg/ml concentration. It additionally could contain an antibiotic from the group of gentamicin, penicillin G and streptomicin. The storage is performed at solution's temperature being 2-8 C. EFFECT: higher efficiency to store corneal tissues, more simplified and cheaper method. 6 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CORNEA STORAGE SOLUTION | 2012 |
|
RU2498570C1 |
| PRESERVING AGENT FOR DONOR CORNEA | 2010 |
|
RU2450515C1 |
| FRACTION OF HYALURONIC ACID OR ITS SALT, METHOD OF PURIFICATION OF THIS FRACTION, METHODS OF PREPARING THIS FRACTION, PHARMACEUTICAL PREPARATION AND AGENTS USED IN OPHTHALMOLOGY | 1992 |
|
RU2128666C1 |
| MEANS FOR PRESERVATION OF THE POSTERIOR LAYER TRANSPLANT OF THE DONOR CORNEA | 2018 |
|
RU2676311C1 |
| UNIVERSAL REMEDY FOR HYPOTHERMIC PRESERVATION OF CORNEA GRAFT | 2019 |
|
RU2710167C1 |
| MEANS FOR ORGANOTYPIC PRESERVATION OF DONOR CORNEA | 2020 |
|
RU2745114C1 |
| DONOR'S CORNEA PRESERVATIVE | 1996 |
|
RU2129364C1 |
| MEDIUM FOR EYE CORNEA CONSERVATION | 1993 |
|
RU2069951C1 |
| METHOD OF CORNEAL GRAFT PREPARATION FOR LAYER-BY-LAYER KERATOPLASTY | 2019 |
|
RU2723135C1 |
| MEDICATION, METHOD OF OBTAINING MEDICATION, AND METHOD OF TREATMENT FOR CORNEA EDEMA AND OTHER EARLY BULLOUS KERATOPATHY MANIFESTATIONS | 2008 |
|
RU2357743C1 |
